Evidence map›Paper›PMID 35891395›Full record

ArticleViruses2022

Development of Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of Human Norovirus Major Capsid Protein.

Yayoi Kimura, Jihye Shin, Yusuke Nakai, Masaya Takahashi, Yoko Ino, Tomoko Akiyama, Keiko Goto, Noriko Nagata, Yutaro Yamaoka, Kei Miyakawa and 2 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Yayoi KimuraAdvanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.
Jihye ShinAdvanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.
Yusuke NakaiAdvanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.
Masaya TakahashiAdvanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.
Yoko InoAdvanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.
Tomoko AkiyamaAdvanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.
Keiko GotoDepartment of Virology, Ibaraki Prefectural Institute of Public Health, Mito 310-0852, Japan.
Noriko NagataDepartment of Virology, Ibaraki Prefectural Institute of Public Health, Mito 310-0852, Japan.
Yutaro YamaokaDepartment of Microbiology, School of Medicine, Yokohama City University, Yokohama 236-0004, Japan.
Kei MiyakawaDepartment of Microbiology, School of Medicine, Yokohama City University, Yokohama 236-0004, Japan.
Hirokazu KimuraDepartment of Health Science, Gunma Paz University Graduate School, Takasaki-shi 370-0006, Japan.
Akihide RyoAdvanced Medical Research Center, Yokohama City University, Yokohama 236-0004, Japan.
Yokohama City University · JPIbaraki Prefectural Police · JPGumma Paz College · JPKanto Chemical (Japan) · JPYokohama City University Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human Norwalk viruses (HuNoVs), the most common etiological agents of acute gastroenteritis, are genetically diverse RNA viruses that frequently cause mass food poisoning internationally. Although nucleic acid detection methods, such as reverse transcription-quantitative polymerase chain reaction (RT-qPCR), are the gold standard for the diagnosis of norovirus infection, alternative methods are needed for the specific and sensitive viral protein detection for rapid diagnosis and surveillance. In this study, we developed a robust and high-throughput targeted proteomic assay workflow to directly detect the VP1 major capsid protein of HuNoVs. A parallel reaction monitoring (PRM) assay using a high-resolution mass spectrometer was used to detect representative peptides derived from VP1 in six different HuNoV genotypes. An optimized protocol using synthesized heavy isotope-labeled peptides as internal standards was also used to simultaneously genotype and quantify the VP1 protein in human stool specimens. This method is expected to become a new tool for studying the molecular epidemiology of HuNoV and to shed new light on targeted proteomics in clinical practice.

Indexed as

Caliciviridae InfectionsNorovirusCapsid ProteinsHumansMass SpectrometryProteomicsCapsid Proteinsmass spectrometrynorovirusNorwalk virusparallel reaction monitoring (PRM)stool specimen

Identifiers

PMID35891395
PMCPMC9319599
OpenAlexW4288205387

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.